Source: European Journal of Pharmacology. Unidade: ICB
Subjects: BIOLOGIA CELULAR, CAQUEXIA, PERDA DE PESO, RECEPTORES ADRENÉRGICOS, NERVOS CRANIANOS, CANABINOIDES, SISTEMA GASTROINTESTINAL, INGESTÃO, CÉLULAS CULTIVADAS DE TUMOR, RATOS, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Mickael Laudrup de Sousa et al. Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats. European Journal of Pharmacology, v. 877, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173087. Acesso em: 27 abr. 2024.APA
Cavalcante, M. L. de S., Silva, M. S., Cavalcante, A. K. M., Santos, R. de O., Nunes, D. D. T., Busquets, S., et al. (2020). Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats. European Journal of Pharmacology, 877, 11 . doi:10.1016/j.ejphar.2020.173087NLM
Cavalcante ML de S, Silva MS, Cavalcante AKM, Santos R de O, Nunes DDT, Busquets S, Argiles JM, Seelaender MCL, Matos Neto EM de, Santos AA dos, Silva MTB da. Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats [Internet]. European Journal of Pharmacology. 2020 ; 877 11 .[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173087Vancouver
Cavalcante ML de S, Silva MS, Cavalcante AKM, Santos R de O, Nunes DDT, Busquets S, Argiles JM, Seelaender MCL, Matos Neto EM de, Santos AA dos, Silva MTB da. Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats [Internet]. European Journal of Pharmacology. 2020 ; 877 11 .[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173087